Search research articles
Contact Us
Filters
Showing results (91-100 of 165) with videos related to
Page
of 17
Sort By:
Cancers
|
March 10, 2022
Reduced Absolute Count of Monocytes in Patients Carrying Hematological Neoplasms and SARS-CoV2 Infection
Alessandra Romano, Claudio Cerchione, Concetta Conticello, et al.
European Journal of Haematology
|
November 24, 2025
Hodgkin-Inflammatory-Based Model ME-IPS Is a New Inflammatory-Based Prognostic Model Calculated at Diagnosis: Results From a Real-Life Study
Andrea Duminuco, Vittorio Del Fabro, Gabriella Santuccio, et al.
Expert Review of Molecular Diagnostics
|
May 1, 2018
PMN-MDSC and arginase are increased in myeloma and may contribute to resistance to therapy
Alessandra Romano, Nunziatina Laura Parrinello, Piera La Cava, et al.
Oncotarget
|
March 12, 2016
Granulocyte-like myeloid derived suppressor cells (G-MDSC) are increased in multiple myeloma and are driven by dysfunctional mesenchymal stem cells (MSC)
Cesarina Giallongo, Daniele Tibullo, Nunziatina L Parrinello, et al.
Leukemia Research
|
August 3, 2010
NF-κB localization in multiple myeloma plasma cells and mesenchymal cells
Concetta Conticello, Raffaella Giuffrida, Luana Adamo, et al.
Journal of Clinical Medicine
|
October 19, 2019
Clinical Benefit of Long-Term Disease Control with Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients
Marina Silvia Parisi, Salvatore Leotta, Alessandra Romano, et al.
Cell Death & Disease
|
October 30, 2019
Correction: TLR4 signaling drives mesenchymal stromal cells commitment to promote tumor microenvironment transformation in multiple myeloma
Cesarina Giallongo, Daniele Tibullo, Giuseppina Camiolo, et al.
Clinical and Experimental Medicine
|
June 27, 2024
Comprehensive analysis of clinical outcomes, infectious complications and microbiological data in newly diagnosed multiple myeloma patients: a retrospective observational study of 92 subjects
Vanessa Desantis, Paola Borrelli, Teresa Panebianco, et al.
Cell Death & Disease
|
September 22, 2019
TLR4 signaling drives mesenchymal stromal cells commitment to promote tumor microenvironment transformation in multiple myeloma
Cesarina Giallongo, Daniele Tibullo, Giuseppina Camiolo, et al.
Biomolecules
|
January 22, 2021
Focus on Osteosclerotic Progression in Primary Myelofibrosis
Mariarita Spampinato, Cesarina Giallongo, Alessandra Romano, et al.
Page
of 17
Search research articles
Search
Showing results (91-100 of 165) with videos related to
Sort By:
Page
of 17
Cancers
|
March 10, 2022
Reduced Absolute Count of Monocytes in Patients Carrying Hematological Neoplasms and SARS-CoV2 Infection
Alessandra Romano, Claudio Cerchione, Concetta Conticello, et al.
European Journal of Haematology
|
November 24, 2025
Hodgkin-Inflammatory-Based Model ME-IPS Is a New Inflammatory-Based Prognostic Model Calculated at Diagnosis: Results From a Real-Life Study
Andrea Duminuco, Vittorio Del Fabro, Gabriella Santuccio, et al.
Expert Review of Molecular Diagnostics
|
May 1, 2018
PMN-MDSC and arginase are increased in myeloma and may contribute to resistance to therapy
Alessandra Romano, Nunziatina Laura Parrinello, Piera La Cava, et al.
Oncotarget
|
March 12, 2016
Granulocyte-like myeloid derived suppressor cells (G-MDSC) are increased in multiple myeloma and are driven by dysfunctional mesenchymal stem cells (MSC)
Cesarina Giallongo, Daniele Tibullo, Nunziatina L Parrinello, et al.
Leukemia Research
|
August 3, 2010
NF-κB localization in multiple myeloma plasma cells and mesenchymal cells
Concetta Conticello, Raffaella Giuffrida, Luana Adamo, et al.
Journal of Clinical Medicine
|
October 19, 2019
Clinical Benefit of Long-Term Disease Control with Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients
Marina Silvia Parisi, Salvatore Leotta, Alessandra Romano, et al.
Cell Death & Disease
|
October 30, 2019
Correction: TLR4 signaling drives mesenchymal stromal cells commitment to promote tumor microenvironment transformation in multiple myeloma
Cesarina Giallongo, Daniele Tibullo, Giuseppina Camiolo, et al.
Clinical and Experimental Medicine
|
June 27, 2024
Comprehensive analysis of clinical outcomes, infectious complications and microbiological data in newly diagnosed multiple myeloma patients: a retrospective observational study of 92 subjects
Vanessa Desantis, Paola Borrelli, Teresa Panebianco, et al.
Cell Death & Disease
|
September 22, 2019
TLR4 signaling drives mesenchymal stromal cells commitment to promote tumor microenvironment transformation in multiple myeloma
Cesarina Giallongo, Daniele Tibullo, Giuseppina Camiolo, et al.
Biomolecules
|
January 22, 2021
Focus on Osteosclerotic Progression in Primary Myelofibrosis
Mariarita Spampinato, Cesarina Giallongo, Alessandra Romano, et al.
Page
of 17